322 purchase as supplier for a total of 648,718.5 between 2009 and 2014.
Overcost in MXN
429,714.3 pesos mexicanos
Overcost in %
546.9 %
| Product | Purchases | Total amount | Overcost in MXN | Overcost in % | Period |
|---|---|---|---|---|---|
| AZATIOPRINA | 22 | 35,799 MXN | 15,269.5 MXN | 146.6 % | 2012 - 2013 |
| INTERFERÓN | 17 | 103,140 MXN | 94,762.9 MXN | 1,131.2 % | 2014 - 2014 |
| LITIO | 13 | 8,953 MXN | 5,110.3 MXN | 838.6 % | 2012 - 2014 |
| IPRATROPIO | 12 | 30,354 MXN | 23,143 MXN | 322.1 % | 2014 - 2014 |
| CINITAPRIDA | 12 | 29,878 MXN | 1,698.5 MXN | 3.33 % | 2012 - 2014 |
| AMIODARONA | 12 | 41,552 MXN | 36,185.9 MXN | 677.9 % | 2012 - 2013 |
| OXCARBAZEPINA | 10 | 8,813.5 MXN | 1,068.6 MXN | 16.3 % | 2012 - 2012 |
| AMITRIPTILINA | 10 | 9,650 MXN | 9,079.5 MXN | 1,586.3 % | 2014 - 2014 |
| RISPERIDONA | 9 | 29,609 MXN | 27,879.3 MXN | 1,832.3 % | 2013 - 2014 |
| CLOMIFENO | 8 | 4,570 MXN | 11.4 MXN | 0.523 % | 2012 - 2014 |
9 contract as supplier for a total of 655,384.8 between 2013 and 2017.
Country
Identifiers
RFC: SALM700212QT0
Date updated in QQW
24 de enero de 2019
Source(s)
Part of the project
Organization responsible for the import